73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Quitting smoking tied to better survival in head, neck squamous cell carcinoma

Quitting smoking tied to better survival in head, neck squamous cell carcinoma

by Lori SolomonSmoking cessation for >10 years is significantly associated with reduced overall mortality and head and neck squamous cell carcinoma (HNSCC)-specific mortality, according to a study

Quitting smoking tied to better survival in head, neck squamous cell carcinoma

by Lori SolomonSmoking cessation for >10 years is significantly associated with reduced overall mortality and head and neck squamous cell carcinoma (HNSCC)-specific mortality, according to a study
Actin cytoskeleton remodeling protects tumor cells against immune attack

Actin cytoskeleton remodeling protects tumor cells against immune attack

by Luxembourg Institute of HealthConfocal microscopy image. Accumulation of actin filaments (in green) at the immunological synapse of a resistant cancer cell in contact with an NK cell (in red). Cell

Actin cytoskeleton remodeling protects tumor cells against immune attack

by Luxembourg Institute of HealthConfocal microscopy image. Accumulation of actin filaments (in green) at the immunological synapse of a resistant cancer cell in contact with an NK cell (in red). Cell
Putting a dollar value on cancer survival

Putting a dollar value on cancer survival

by University of the Sunshine CoastCredit: Pixabay/CC0 Public DomainNew University of the Sunshine Coast-led research has for the first time estimated the health care costs of Queenslanders who surviv

Putting a dollar value on cancer survival

by University of the Sunshine CoastCredit: Pixabay/CC0 Public DomainNew University of the Sunshine Coast-led research has for the first time estimated the health care costs of Queenslanders who surviv
FDA approves Abecma for relapsed, refractory multiple myeloma

FDA approves Abecma for relapsed, refractory multiple myeloma

by Lori SolomonThe U.S. Food and Drug Administration has approved Abecma (idecabtagene vicleucel) as a personalized CAR T-cell therapy for triple-class exposed relapsed or refractory multiple myeloma.

FDA approves Abecma for relapsed, refractory multiple myeloma

by Lori SolomonThe U.S. Food and Drug Administration has approved Abecma (idecabtagene vicleucel) as a personalized CAR T-cell therapy for triple-class exposed relapsed or refractory multiple myeloma.
Predicting prostate cancer recurrence 15 months sooner

Predicting prostate cancer recurrence 15 months sooner

by Steve Martin,Purdue UniversityGraphical abstract. Credit:iScience(2022). DOI: 10.1016/j.isci.2022.105430A Purdue University mechanical engineer and his international collaborators

Predicting prostate cancer recurrence 15 months sooner

by Steve Martin,Purdue UniversityGraphical abstract. Credit:iScience(2022). DOI: 10.1016/j.isci.2022.105430A Purdue University mechanical engineer and his international collaborators
Molecular jackhammers drill pathway to killing cancer cells  

Molecular jackhammers drill pathway to killing cancer cells  

JANUARY 19, 2024by Michelle Revels,Texas A&M University College of EngineeringResearchers have developed a technique that employs nanoscopic molecular jackhammers capable of cracking a cell&

Molecular jackhammers drill pathway to killing cancer cells  

JANUARY 19, 2024by Michelle Revels,Texas A&M University College of EngineeringResearchers have developed a technique that employs nanoscopic molecular jackhammers capable of cracking a cell&
Quantitative pathologic analysis may help predict prognosis in colorectal cancer

Quantitative pathologic analysis may help predict prognosis in colorectal cancer

The quantitative segmentation algorithm (QuantCRC) may improve the prediction of prognosis in colorectal cancer (CRC), according to a study published online Aug. 16 inGastroenterology.Reetesh K.

Quantitative pathologic analysis may help predict prognosis in colorectal cancer

The quantitative segmentation algorithm (QuantCRC) may improve the prediction of prognosis in colorectal cancer (CRC), according to a study published online Aug. 16 inGastroenterology.Reetesh K.
Scientists create an scRNA-seq atlas of the multiple myeloma immune microenvironment across disease stages

Scientists create an scRNA-seq atlas of the multiple myeloma immune microenvironment across disease stages

byVIB (the Flanders Institute for Biotechnology)The MM microenvironment is characterized by the presence of T cells with an exhausted phenotype. Credit:Journal of Hematology & Oncology

Scientists create an scRNA-seq atlas of the multiple myeloma immune microenvironment across disease stages

byVIB (the Flanders Institute for Biotechnology)The MM microenvironment is characterized by the presence of T cells with an exhausted phenotype. Credit:Journal of Hematology & Oncology
Radiation/cisplatin combination established as standard of care for HPV+ oral cancer

Radiation/cisplatin combination established as standard of care for HPV+ oral cancer

byAmerican Society for Radiation OncologyCombinations of radiation and chemotherapy drugs have been shown to cure HPV-related head and neck cancer with a high success rate. A new phase III trial

Radiation/cisplatin combination established as standard of care for HPV+ oral cancer

byAmerican Society for Radiation OncologyCombinations of radiation and chemotherapy drugs have been shown to cure HPV-related head and neck cancer with a high success rate. A new phase III trial
Preoperative immunotherapy for mesothelioma shows favorable outcomes

Preoperative immunotherapy for mesothelioma shows favorable outcomes

by Dipali Pathak,Baylor College of MedicineCredit: Pixabay/CC0 Public DomainIn a study published recently in the journalClinical Cancer Research, researchers at Baylor College of Medicine

Preoperative immunotherapy for mesothelioma shows favorable outcomes

by Dipali Pathak,Baylor College of MedicineCredit: Pixabay/CC0 Public DomainIn a study published recently in the journalClinical Cancer Research, researchers at Baylor College of Medicine
Lung nodule program provides benefits to patients ineligible for lung cancer screening

Lung nodule program provides benefits to patients ineligible for lung cancer screening

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainAdopting a lung nodule program (LNP) may increase the detection of early lung cancer for patients who are not

Lung nodule program provides benefits to patients ineligible for lung cancer screening

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainAdopting a lung nodule program (LNP) may increase the detection of early lung cancer for patients who are not